Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

ABS Change Packet

UCA | CDC Antibiotic Stewardship Quality Improvement (QI) Program

November 2022 – September 2023

RESULTS:

“Evaluating the Effect of an Urgent Care Antibiotic Stewardship Intervention: A Multi-Network Collaborative Effort”

CHANGE PACKET

Select from the resources below the intervention(s) to deploy during your current PDSA cycle for the QI Program.

The Urgent Care Association (UCA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The successful completion of the Antibiotic Stewardship Quality Improvement Project activity, which includes participation in the evaluation component, enables the participant to earn a maximum of:

  • 25 MA PRA Category 1 Credit(s)™; and
  • 25 MOC Points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program; and
  • 25 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program; or
  • Part IV MOC via the American Board of Medical Specialties (ABMS)

Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participation in this CME activity includes sharing participant information with the ABIM, ABP and ABMS Boards via ACCME’s PARS and ABMS MOCAM.

Goals: Participants will commit to antibiotic stewardship following a plan data collection, implementing stewardship efforts, and continuous feedback. Progress will be measured with a goal of demonstrating a decrease in inappropriate antibiotic prescribing, 9-mo out from the baseline, improving patient outcomes.

CME Participation: Providers must attend a minimum of (4) webinars during the 9-mo program; participate actively in the implementation of the selected intervention(s); participate in selected feedback mechanism to evaluate progress; complete activity evaluation component.

Disclosure information for this activity:

Planners, Faculty, Reviewers, Other

  • Seema Awatramani, MD: Nothing to disclose
  • Sabrina Balthrop: Nothing to disclose
  • Jacqueline Corboy, MD: Nothing to disclose
  • Patrick Dolan, MD: Nothing to disclose
  • Rana Hamdy, MD: Nothing to disclose
  • Sue Holzkopf: Nothing to disclose
  • Cindy Liu, MD: Trench Therapeutics
  • Amanda Nedved, MD: Pfizer, EBMedicine
  • Daniel Park, MSPH: Nothing to disclose
  • Laurel Stoimenoff: Nothing to disclose
  • Joseph Toscano: Nothing to disclose
  • Melodie Turk, MHA: Nothing to disclose
  • Todd Windley: Nothing to disclose
  • Kimberly Youngblood: Nothing to disclose
  • JD Zipkin, MD: Visby Medical

Commercial Support: This activity did not receive any commercial support.